Search Results

Prognostic Value of Estrogen Receptor Co-activator AIB1 in Metastatic Breast Cancer Patients Treated with a Combination of Ribociclib and Letrozole.

• Authors : Cavdar, Eyyup¹ (AUTHOR) ; Karaboyun, Kubilay² (AUTHOR) ; Iriagac, Yakup³ (AUTHOR)

• Source: Bratislava Medical Journal / Bratislavské Lekárske Listy. Oct2025, Vol. 126 Issue 10, p2721-2727. 7p.

Record details

Myeloperoxidase expressing tumor associated neutrophils are associated with worse prognosis in metastatic breast cancer patients.

• Authors : Leandersson, Karin¹ (AUTHOR) ; Blomgård, Dag¹ (AUTHOR); Tuvesson, Oscar¹ (AUTHOR)

• Source: Scientific Reports. 7/12/2025, Vol. 15 Issue 1, p1-11. 11p.

Record details

Prognostic Factors and Their Impact on Survival in Patients with De Novo Metastatic Breast Cancer.

• Authors : ERDIS, Eda¹ ; YILMAZ, Mukaddes²; UCAR, Mahmut²

• Source: UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi. 2025, Vol. 35 Issue 1, p41-50. 10p.

Record details

Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapy.

• Authors : Moukas, Stefanos Ioannis¹ (AUTHOR) ; Dohn, Merle¹ (AUTHOR); Lehnerdt, Catrin² (AUTHOR)

• Source: Scientific Reports. 3/25/2025, Vol. 15 Issue 1, p1-15. 15p.

Record details

Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer.

• Authors : Ceylan, Furkan¹ (AUTHOR) ; Mehdiyev, Mirmehdi¹ (AUTHOR); Dede, Didem Şener^1,2 (AUTHOR)

• Source: Journal of Clinical Medicine. Jan2025, Vol. 14 Issue 1, p173. 15p.

Record details

Beyond the median: Estimating survival times for patients starting endocrine therapy for estrogen receptor‐positive, metastatic breast cancer from recent randomized trials.

• Authors : Parsonson, Andrew O.^1,2 (AUTHOR) ; Sarkar, Sunit³ (AUTHOR); Brown, Lauren⁴ (AUTHOR)

• Source: Asia Pacific Journal of Clinical Oncology. Dec2024, Vol. 20 Issue 6, p714-722. 9p.

Record details

Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody–drug conjugates efficacy in metastatic breast cancer

• Authors : Seban, Romain-David; Champion, Laurence; de Moura, Alexandre ...

Subjects: [18F]FDG PET/CT; Adult; Tumor dissemination

• Source: European Journal of Nuclear Medicine and Molecular Imaging. 52:708-718

Record details

Subdivision of M1 category and prognostic stage for de novo metastatic breast cancer to enhance prognostic prediction and guide the selection of locoregional therapy

• Authors : Lei Ji; Ge Song; Min Xiao

Subjects: Adult; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; Breast Neoplasms

• Source: Thorac CancerThoracic Cancer, Vol 15, Iss 30, Pp 2193-2205 (2024)

Record details

Complete response and long-term survival to endocrine monotherapy in a patient with metastatic breast cancer in a low-income country: a case report.

• Authors : Sada, Raghad¹ (AUTHOR); Karim, Nouralhuda¹ (AUTHOR); Rohaibani, Ghina¹ (AUTHOR)

• Source: Journal of Medical Case Reports. 9/4/2024, Vol. 18 Issue 1, p1-5. 5p.

Record details

The Combined Assessment of CTC and ESR1 Status in Liquid Biopsy Samples Enhances the Clinical Value of Prediction in Metastatic Breast Cancer.

• Authors : Szostakowska-Rodzos, Malgorzata¹ (AUTHOR); Grzybowska, Ewa A.^1,2 (AUTHOR) ; Mysliwy, Izabella^1,3 (AUTHOR)

• Source: International Journal of Molecular Sciences. Mar2025, Vol. 26 Issue 5, p2038. 15p.

Record details